Work

Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT).

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.6_suppl.567

Authors: Deaglan Joseph McHugh, Samuel Funt, Deborah Silber, Andrea Knezevic, Sujata Patil, Devon O'Donnell, Stephanie Tsai, Victor E. Reuter, Joel Sheinfeld, Brett Stewart Carver, Robert J. Motzer, Dean F. Bajorin, George J. Bosl, Darren R. Feldman

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Testicular diseases and treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2793584115

Cites:

Cited by:

Related to: 10